Cargando…
Metformin Impedes Oxidation of LDL In Vitro
Metformin is the most commonly prescribed glucose-lowering drug for the treatment of type 2 diabetes. The aim of this study was to investigate whether metformin is capable of impeding the oxidation of LDL, a crucial step in the development of endothelial dysfunction and atherosclerosis. LDL was oxid...
Autores principales: | Rossmann, Christine, Ranz, Cornelia, Kager, Gerd, Ledinski, Gerhard, Koestenberger, Martin, Wonisch, Willibald, Wagner, Thomas, Schwaminger, Sebastian P., Di Geronimo, Bruno, Hrzenjak, Andelko, Hallstöm, Seth, Reibnegger, Gilbert, Cvirn, Gerhard, Paar, Margret |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459002/ https://www.ncbi.nlm.nih.gov/pubmed/37631325 http://dx.doi.org/10.3390/pharmaceutics15082111 |
Ejemplares similares
-
Ethyl pyruvate inhibits oxidation of LDL in vitro and attenuates oxLDL toxicity in EA.hy926 cells
por: Rossmann, Christine, et al.
Publicado: (2018) -
Only Subclinical Alterations in the Haemostatic System of People with Diabetes after COVID-19 Vaccination
por: Paar, Margret, et al.
Publicado: (2022) -
The Antiplatelet Action of S-Nitroso Human Serum Albumin in Whole Blood
por: Tsiountsioura, Melina, et al.
Publicado: (2022) -
Cultivation and Immortalization of Human B-Cells Producing a Human Monoclonal IgM Antibody Binding to MDA-LDL: Further Evidence for Formation of Atherogenic MDA-LDL Adducts in Humans In Vivo
por: Tatzber, Franz, et al.
Publicado: (2017) -
Orthostatic Challenge Shifts the Hemostatic System of Patients Recovered from Stroke toward Hypercoagulability
por: Cvirn, Gerhard, et al.
Publicado: (2017)